Testing effectiveness (Phase 2)Study completedNCT03789019
What this trial is testing
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 29